Brief: Femasys Inc. Secures Additional Financing With Strategic Investment From Investors Led By Pharmacyte Biotech
15/11/2023 12:34
Nov 15 (Reuters) - Femasys Inc FEMY.O :
* FEMASYS INC. SECURES ADDITIONAL FINANCING WITH STRATEGIC
INVESTMENT FROM INVESTORS LED BY PHARMACYTE BIOTECH
* FEMASYS INC - $6.85 MILLION UPFRONT INVESTMENT PROVIDES
$23
MILLION TOTAL CASH RUNWAY INTO SECOND HALF 2025
* FEMASYS- STRATEGIC INVESTMENT IN CO IS IN FORM OF $6.85
MILLION
AMOUNT OF A SENIOR UNSECURED CONVERTIBLE NOTE WHICH MATURES
NOVEMBER 2025
Source text for Eikon: ID:nGNX8Nczq3
Further company coverage: FEMY.O
((Reuters.Briefs@thomsonreuters.com))
Recent news on Pharmacyte Biotech
See all newsBrief: Pharmacyte Biotech Inc - Increases Stake In Tnf Pharmaceuticals By $3 Million
Brief: PharmaCyte Biotech Makes $7 Million Strategic Investment in MyMD, A Biopharmaceutical Company Focused on Inflammatory Disease
Brief: Pharmacyte Biotech Acquires $5 Million Stake In Emerging Women’S Health Innovator Femasys
Brief: Femasys Inc. Secures Additional Financing With Strategic Investment From Investors Led By Pharmacyte Biotech
Brief: Pharmacyte Biotech Announces Final Results Of Tender Offer